184 related articles for article (PubMed ID: 3784897)
1. Gd(DOTA): an alternative to Gd(DTPA) as a T1,2 relaxation agent for NMR imaging or spectroscopy.
Magerstädt M; Gansow OA; Brechbiel MW; Colcher D; Baltzer L; Knop RH; Girton ME; Naegele M
Magn Reson Med; 1986 Oct; 3(5):808-12. PubMed ID: 3784897
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium cryptelates as MR contrast agents.
Knop RH; Frank JA; Dwyer AJ; Girton ME; Naegele M; Schrader M; Cobb J; Gansow O; Maegerstadt M; Brechbiel M
J Comput Assist Tomogr; 1987; 11(1):35-42. PubMed ID: 3805426
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of two new gadolinium chelates as contrast agents for MRI.
Wiegers CB; Welch MJ; Sharp TL; Brown JJ; Perman WH; Sun Y; Motekaitis RJ; Martell AE
Magn Reson Imaging; 1992; 10(6):903-11. PubMed ID: 1461088
[TBL] [Abstract][Full Text] [Related]
4. Prediction of q-values and conformations of gadolinium chelates for magnetic resonance imaging.
Castonguay LA; Treasurywala AM; Caulfield TJ; Jaeger EP; Kellar KE
Bioconjug Chem; 1999; 10(6):958-64. PubMed ID: 10563764
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium-DOTA enhanced MR imaging of intracranial lesions.
Parizel PM; Degryse HR; Gheuens J; Martin JJ; Van Vyve M; De La Porte C; Selosse P; Van de Heyning P; De Schepper AM
J Comput Assist Tomogr; 1989; 13(3):378-85. PubMed ID: 2723166
[TBL] [Abstract][Full Text] [Related]
6. Gd-DOTA: characterization of a new paramagnetic complex.
Bousquet JC; Saini S; Stark DD; Hahn PF; Nigam M; Wittenberg J; Ferrucci JT
Radiology; 1988 Mar; 166(3):693-8. PubMed ID: 3340763
[TBL] [Abstract][Full Text] [Related]
7. Magnetic field dependence of solvent proton relaxation rates induced by Gd3+ and Mn2+ complexes of various polyaza macrocyclic ligands: implications for NMR imaging.
Geraldes CF; Sherry AD; Brown RD; Koenig SH
Magn Reson Med; 1986 Apr; 3(2):242-50. PubMed ID: 3086656
[TBL] [Abstract][Full Text] [Related]
8. The measurement of extracellular water volumes in tissues by gadolinium modification of 1H-NMR spin lattice (T1) relaxation.
Braunschweiger PG; Schiffer L; Furmanski P
Magn Reson Imaging; 1986; 4(4):285-91. PubMed ID: 3118123
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of polyaza macrocyclic methylene phosphonate chelates of Gd3+ ions as MRI contrast agents.
Geraldes CF; Brown RD; Cacheris WP; Koenig SH; Sherry AD; Spiller M
Magn Reson Med; 1989 Jan; 9(1):94-104. PubMed ID: 2540397
[TBL] [Abstract][Full Text] [Related]
10. Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates.
Nwe K; Bernardo M; Regino CA; Williams M; Brechbiel MW
Bioorg Med Chem; 2010 Aug; 18(16):5925-31. PubMed ID: 20663676
[TBL] [Abstract][Full Text] [Related]
11. MR imaging of rat brain glioma: Gd-DTPA versus Gd-DOTA.
Runge VM; Jacobson S; Wood ML; Kaufman D; Adelman LS
Radiology; 1988 Mar; 166(3):835-8. PubMed ID: 3401296
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
[TBL] [Abstract][Full Text] [Related]
13. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
[TBL] [Abstract][Full Text] [Related]
14. Gd-25 DTPA-MAb, a potential NMR contrast agent for MRI in the xenografted nude mouse: preliminary studies.
Curtet C; Bourgoin C; Bohy J; Saccavini JC; Thédrez P; Akoka S; Tellier C; Chatal JF
Int J Cancer Suppl; 1988; 2():126-32. PubMed ID: 3280506
[TBL] [Abstract][Full Text] [Related]
15. Synthesis neutral rare earth complexes of diethylenetriamine-N,N''-bis(acetyl-isoniazid)-N,N',N''-triacetic acid as potential contrast enhancement agents for magnetic resonance imaging.
Zhang DW; Yang ZY; Wang BD; Zhang SP; Yang RD
Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1203-6. PubMed ID: 16880671
[TBL] [Abstract][Full Text] [Related]
16. Novel gadolinium(III) polyaminocarboxylate macrocyclic complexes as potential magnetic resonance imaging contrast agents.
Chan KW; Barra S; Botta M; Wong WT
J Inorg Biochem; 2004 May; 98(5):677-82. PubMed ID: 15134912
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the biodistribution of 153Gd-labeled Gd(DTPA)2-, Gd(DOTA)-, and Gd(acetate)n in mice.
Wedeking P; Tweedle M
Int J Rad Appl Instrum B; 1988; 15(4):395-402. PubMed ID: 3255735
[TBL] [Abstract][Full Text] [Related]
18. Ultraviolet and magnetic-circular-dichroic spectroscopic studies of Gd(III) complexed with diethylenetriaminepentaacetic acid. A contrast agent for NMR imaging.
Bligh SW; Drake AF; Sadler PJ
Eur J Biochem; 1989 Apr; 181(1):223-4. PubMed ID: 2714280
[TBL] [Abstract][Full Text] [Related]
19. Renal tolerance of gadolinium-DOTA and gadolinium-DTPA in rats.
Brillet G; Dubois M; Beaufils H; Bourbouze R; Deray G
Invest Radiol; 1994 Mar; 29(3):352-4. PubMed ID: 8175311
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
